| In recent years, the number of data integrity violations in the pharmaceutical industry has risen significantly. In 2019, over 65% of all FDA Warning Letters addressed data governance and data integrity deficiencies. Therefore, an increasing number of companies are turning to integrated informatics solutions to manage their data handling and ensure integrity. In response, manufacturers are streamlining workflow solutions featuring cross-instrument data integration that not only reduce the potential for error, but also limit data redundancy while covering all GMP/GLP regulations.
Here's a look at how reducing instruments in your workflow can actually help improve data integrity. Get Infographic |
